Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma
Protein tyrosine phosphatase nonreceptor type 2 (PTPN2) is a promising target for sensitizing solid tumors to immune checkpoint blockades. However, the highly polar active sites of PTPN2 hinder drug discovery efforts. Leveraging small interfering RNA (siRNA) technology, we developed a novel glutathi...
Saved in:
| Main Authors: | Fu Wang, Haoyu You, Huahua Liu, Zhuoran Qi, Xuan Shi, Zhiping Jin, Qingyang Zhong, Taotao Liu, Xizhong Shen, Sergii Rudiuk, Jimin Zhu, Tao Sun, Chen Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525001522 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The phosphatases TCPTP, PTPN22, and SHP1 play unique roles in T cell phosphotyrosine maintenance and feedback regulation of the TCR
by: Aurora Callahan, et al.
Published: (2025-07-01) -
Phosphatase Dysregulation in Cancer: Signaling Pathways and Therapeutic Opportunities
by: Maryam Jama, et al.
Published: (2025-06-01) -
The roles of pleiotrophin in brain injuries: a narrative review of the literature
by: Yupeng Lei, et al.
Published: (2025-12-01) -
A lethal DENV-2 wild-type mouse model for mutagenesis investigations
by: Zhiran Qin, et al.
Published: (2025-07-01) -
The role of type I interferon signaling in myeloid anti-tumor immunity
by: Sofie Patrizia Meyer, et al.
Published: (2025-03-01)